دورية أكاديمية
أعرض في EDS

Lenalidomide and dexamethasone in transplant-ineligible patients with myeloma

التفاصيل البيبلوغرافية
العنوان: Lenalidomide and dexamethasone in transplant-ineligible patients with myeloma
المؤلفون: Benboubker, Lotfi, Dimopoulos, Meletios A., Dispenzieri, Angela, Catalano, John, Belch, Andrew R., Cavo, Michele, Pinto, Antonello, Weisel, Katja, Ludwig, Heinz, Bahlis, Nizar, Banos, Anne, Tiab, Mourad, Delforge, Michel, Cavenagh, Jamie, Geraldes, Catarina, Lee, Je-Jung, Chen, Christine, Oriol, Albert, De La Rubia, Javier, Qiu, Lugui, White, Darrell J., Binder, Daniel, Anderson, Kenneth, Fermand, Jean-Paul, Moreau, Philippe, Attal, Michel, Knight, Robert, Chen, Guang, Van Oostendorp, Jason, Jacques, Christian, Ervin-Haynes, Annette, Avet-Loiseau, Hervé, Hulin, Cyrille, Facon, Thierry, petrini, mario
المساهمون: Benboubker, Lotfi, Dimopoulos, Meletios A., Dispenzieri, Angela, Catalano, John, Belch, Andrew R., Cavo, Michele, Pinto, Antonello, Weisel, Katja, Ludwig, Heinz, Bahlis, Nizar, Banos, Anne, Tiab, Mourad, Delforge, Michel, Cavenagh, Jamie, Geraldes, Catarina, Lee, Je-Jung, Chen, Christine, Oriol, Albert, De La Rubia, Javier, Qiu, Lugui, White, Darrell J., Binder, Daniel, Anderson, Kenneth, Fermand, Jean-Paul, Moreau, Philippe, Attal, Michel, Knight, Robert, Chen, Guang, Van Oostendorp, Jason, Jacques, Christian, Ervin-Haynes, Annette, Avet-Loiseau, Hervã©, Hulin, Cyrille, Facon, Thierry, Petrini, Mario
سنة النشر: 2014
المجموعة: ARPI - Archivio della Ricerca dell'Università di Pisa
مصطلحات موضوعية: Adult, Aged, 80 and over, Antineoplastic Combined Chemotherapy Protocol, Dexamethasone, Disease-Free Survival, Female, Human, Kaplan-Meier Estimate, Male, Melphalan, Middle Aged, Multiple Myeloma, Prednisone, Thalidomide, Medicine (all)
الوصف: Background: The combination melphalan-prednisone-thalidomide (MPT) is considered a standard therapy for patients with myeloma who are ineligible for stem-cell transplantation. However, emerging data on the use of lenalidomide and low-dose dexamethasone warrant a prospective comparison of the two approaches. Methods: We randomly assigned 1623 patients to lenalidomide and dexamethasone in 28-day cycles until disease progression (535 patients), to the same combination for 72 weeks (18 cycles; 541 patients), or to MPT for 72 weeks (547 patients). The primary end point was progression-free survival with continuous lenalidomide-dexamethasone versus MPT. Results: The median progression-free survival was 25.5 months with continuous lenalidomide-dexamethasone, 20.7 months with 18 cycles of lenalidomide-dexamethasone, and 21.2 months with MPT (hazard ratio for the risk of progression or death, 0.72 for continuous lenalidomide-dexamethasone vs. MPT and 0.70 for continuous lenalidomide-dexamethasone vs. 18 cycles of lenalidomide-dexamethasone; P<0.001 for both comparisons). Continuous lenalidomide-dexamethasone was superior to MPT for all secondary efficacy end points, including overall survival (at the interim analysis). Overall survival at 4 years was 59% with continuous lenalidomide-dexamethasone, 56% with 18 cycles of lenalidomide-dexamethasone, and 51% with MPT. Grade 3 or 4 adverse events were somewhat less frequent with continuous lenalidomide-dexamethasone than with MPT (70% vs. 78%). As compared with MPT, continuous lenalidomide-dexamethasone was associated with fewer hematologic and neurologic toxic events, a moderate increase in infections, and fewer second primary hematologic cancers. Conclusions: As compared with MPT, continuous lenalidomide-dexamethasone given until disease progression was associated with a significant improvement in progression-free survival, with an overall survival benefit at the interim analysis, among patients with newly diagnosed multiple myeloma who were ineligible for stem-cell ...
نوع الوثيقة: article in journal/newspaper
اللغة: English
العلاقة: info:eu-repo/semantics/altIdentifier/pmid/25184863; info:eu-repo/semantics/altIdentifier/wos/WOS:000341390600008; volume:371; issue:10; firstpage:906; lastpage:917; numberofpages:12; journal:NEW ENGLAND JOURNAL OF MEDICINE; http://hdl.handle.net/11568/884323Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-84907012637
DOI: 10.1056/NEJMoa1402551
الإتاحة: https://doi.org/10.1056/NEJMoa1402551Test
http://hdl.handle.net/11568/884323Test
رقم الانضمام: edsbas.DD3E258F
قاعدة البيانات: BASE
ResultId 1
Header edsbas
BASE
edsbas.DD3E258F
785
3
Academic Journal
academicJournal
784.518249511719
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsbas&AN=edsbas.DD3E258F&custid=s6537998&authtype=sso
FullText Array ( [Availability] => 0 )
Array ( [0] => Array ( [Url] => https://doi.org/10.1056/NEJMoa1402551# [Name] => EDS - BASE [Category] => fullText [Text] => View record in BASE [MouseOverText] => View record in BASE ) )
Items Array ( [Name] => Title [Label] => Title [Group] => Ti [Data] => Lenalidomide and dexamethasone in transplant-ineligible patients with myeloma )
Array ( [Name] => Author [Label] => Authors [Group] => Au [Data] => &lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Benboubker%2C+Lotfi%22&quot;&gt;Benboubker, Lotfi&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Dimopoulos%2C+Meletios+A%2E%22&quot;&gt;Dimopoulos, Meletios A.&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Dispenzieri%2C+Angela%22&quot;&gt;Dispenzieri, Angela&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Catalano%2C+John%22&quot;&gt;Catalano, John&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Belch%2C+Andrew+R%2E%22&quot;&gt;Belch, Andrew R.&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Cavo%2C+Michele%22&quot;&gt;Cavo, Michele&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Pinto%2C+Antonello%22&quot;&gt;Pinto, Antonello&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Weisel%2C+Katja%22&quot;&gt;Weisel, Katja&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Ludwig%2C+Heinz%22&quot;&gt;Ludwig, Heinz&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Bahlis%2C+Nizar%22&quot;&gt;Bahlis, Nizar&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Banos%2C+Anne%22&quot;&gt;Banos, Anne&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Tiab%2C+Mourad%22&quot;&gt;Tiab, Mourad&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Delforge%2C+Michel%22&quot;&gt;Delforge, Michel&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Cavenagh%2C+Jamie%22&quot;&gt;Cavenagh, Jamie&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Geraldes%2C+Catarina%22&quot;&gt;Geraldes, Catarina&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Lee%2C+Je-Jung%22&quot;&gt;Lee, Je-Jung&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Chen%2C+Christine%22&quot;&gt;Chen, Christine&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Oriol%2C+Albert%22&quot;&gt;Oriol, Albert&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22De+La+Rubia%2C+Javier%22&quot;&gt;De La Rubia, Javier&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Qiu%2C+Lugui%22&quot;&gt;Qiu, Lugui&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22White%2C+Darrell+J%2E%22&quot;&gt;White, Darrell J.&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Binder%2C+Daniel%22&quot;&gt;Binder, Daniel&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Anderson%2C+Kenneth%22&quot;&gt;Anderson, Kenneth&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Fermand%2C+Jean-Paul%22&quot;&gt;Fermand, Jean-Paul&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Moreau%2C+Philippe%22&quot;&gt;Moreau, Philippe&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Attal%2C+Michel%22&quot;&gt;Attal, Michel&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Knight%2C+Robert%22&quot;&gt;Knight, Robert&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Chen%2C+Guang%22&quot;&gt;Chen, Guang&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Van+Oostendorp%2C+Jason%22&quot;&gt;Van Oostendorp, Jason&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Jacques%2C+Christian%22&quot;&gt;Jacques, Christian&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Ervin-Haynes%2C+Annette%22&quot;&gt;Ervin-Haynes, Annette&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Avet-Loiseau%2C+HervÃ&#169;%22&quot;&gt;Avet-Loiseau, HervÃ&#169;&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Hulin%2C+Cyrille%22&quot;&gt;Hulin, Cyrille&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Facon%2C+Thierry%22&quot;&gt;Facon, Thierry&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22petrini%2C+mario%22&quot;&gt;petrini, mario&lt;/searchLink&gt; )
Array ( [Name] => Author [Label] => Contributors [Group] => Au [Data] => Benboubker, Lotfi&lt;br /&gt;Dimopoulos, Meletios A.&lt;br /&gt;Dispenzieri, Angela&lt;br /&gt;Catalano, John&lt;br /&gt;Belch, Andrew R.&lt;br /&gt;Cavo, Michele&lt;br /&gt;Pinto, Antonello&lt;br /&gt;Weisel, Katja&lt;br /&gt;Ludwig, Heinz&lt;br /&gt;Bahlis, Nizar&lt;br /&gt;Banos, Anne&lt;br /&gt;Tiab, Mourad&lt;br /&gt;Delforge, Michel&lt;br /&gt;Cavenagh, Jamie&lt;br /&gt;Geraldes, Catarina&lt;br /&gt;Lee, Je-Jung&lt;br /&gt;Chen, Christine&lt;br /&gt;Oriol, Albert&lt;br /&gt;De La Rubia, Javier&lt;br /&gt;Qiu, Lugui&lt;br /&gt;White, Darrell J.&lt;br /&gt;Binder, Daniel&lt;br /&gt;Anderson, Kenneth&lt;br /&gt;Fermand, Jean-Paul&lt;br /&gt;Moreau, Philippe&lt;br /&gt;Attal, Michel&lt;br /&gt;Knight, Robert&lt;br /&gt;Chen, Guang&lt;br /&gt;Van Oostendorp, Jason&lt;br /&gt;Jacques, Christian&lt;br /&gt;Ervin-Haynes, Annette&lt;br /&gt;Avet-Loiseau, Hervã&#169;&lt;br /&gt;Hulin, Cyrille&lt;br /&gt;Facon, Thierry&lt;br /&gt;Petrini, Mario )
Array ( [Name] => DatePubCY [Label] => Publication Year [Group] => Date [Data] => 2014 )
Array ( [Name] => Subset [Label] => Collection [Group] => HoldingsInfo [Data] => ARPI - Archivio della Ricerca dell&#39;Universit&#224; di Pisa )
Array ( [Name] => Subject [Label] => Subject Terms [Group] => Su [Data] => &lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22Adult%22&quot;&gt;Adult&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22Aged%22&quot;&gt;Aged&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%2280+and+over%22&quot;&gt;80 and over&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22Antineoplastic+Combined+Chemotherapy+Protocol%22&quot;&gt;Antineoplastic Combined Chemotherapy Protocol&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22Dexamethasone%22&quot;&gt;Dexamethasone&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22Disease-Free+Survival%22&quot;&gt;Disease-Free Survival&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22Female%22&quot;&gt;Female&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22Human%22&quot;&gt;Human&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22Kaplan-Meier+Estimate%22&quot;&gt;Kaplan-Meier Estimate&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22Male%22&quot;&gt;Male&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22Melphalan%22&quot;&gt;Melphalan&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22Middle+Aged%22&quot;&gt;Middle Aged&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22Multiple+Myeloma%22&quot;&gt;Multiple Myeloma&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22Prednisone%22&quot;&gt;Prednisone&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22Thalidomide%22&quot;&gt;Thalidomide&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22Medicine+%28all%29%22&quot;&gt;Medicine (all)&lt;/searchLink&gt; )
Array ( [Name] => Abstract [Label] => Description [Group] => Ab [Data] => Background: The combination melphalan-prednisone-thalidomide (MPT) is considered a standard therapy for patients with myeloma who are ineligible for stem-cell transplantation. However, emerging data on the use of lenalidomide and low-dose dexamethasone warrant a prospective comparison of the two approaches. Methods: We randomly assigned 1623 patients to lenalidomide and dexamethasone in 28-day cycles until disease progression (535 patients), to the same combination for 72 weeks (18 cycles; 541 patients), or to MPT for 72 weeks (547 patients). The primary end point was progression-free survival with continuous lenalidomide-dexamethasone versus MPT. Results: The median progression-free survival was 25.5 months with continuous lenalidomide-dexamethasone, 20.7 months with 18 cycles of lenalidomide-dexamethasone, and 21.2 months with MPT (hazard ratio for the risk of progression or death, 0.72 for continuous lenalidomide-dexamethasone vs. MPT and 0.70 for continuous lenalidomide-dexamethasone vs. 18 cycles of lenalidomide-dexamethasone; P&lt;0.001 for both comparisons). Continuous lenalidomide-dexamethasone was superior to MPT for all secondary efficacy end points, including overall survival (at the interim analysis). Overall survival at 4 years was 59% with continuous lenalidomide-dexamethasone, 56% with 18 cycles of lenalidomide-dexamethasone, and 51% with MPT. Grade 3 or 4 adverse events were somewhat less frequent with continuous lenalidomide-dexamethasone than with MPT (70% vs. 78%). As compared with MPT, continuous lenalidomide-dexamethasone was associated with fewer hematologic and neurologic toxic events, a moderate increase in infections, and fewer second primary hematologic cancers. Conclusions: As compared with MPT, continuous lenalidomide-dexamethasone given until disease progression was associated with a significant improvement in progression-free survival, with an overall survival benefit at the interim analysis, among patients with newly diagnosed multiple myeloma who were ineligible for stem-cell ... )
Array ( [Name] => TypeDocument [Label] => Document Type [Group] => TypDoc [Data] => article in journal/newspaper )
Array ( [Name] => Language [Label] => Language [Group] => Lang [Data] => English )
Array ( [Name] => NoteTitleSource [Label] => Relation [Group] => SrcInfo [Data] => info:eu-repo/semantics/altIdentifier/pmid/25184863; info:eu-repo/semantics/altIdentifier/wos/WOS:000341390600008; volume:371; issue:10; firstpage:906; lastpage:917; numberofpages:12; journal:NEW ENGLAND JOURNAL OF MEDICINE; http://hdl.handle.net/11568/884323; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-84907012637 )
Array ( [Name] => DOI [Label] => DOI [Group] => ID [Data] => 10.1056/NEJMoa1402551 )
Array ( [Name] => URL [Label] => Availability [Group] => URL [Data] => https://doi.org/10.1056/NEJMoa1402551&lt;br /&gt;http://hdl.handle.net/11568/884323 )
Array ( [Name] => AN [Label] => Accession Number [Group] => ID [Data] => edsbas.DD3E258F )
RecordInfo Array ( [BibEntity] => Array ( [Identifiers] => Array ( [0] => Array ( [Type] => doi [Value] => 10.1056/NEJMoa1402551 ) ) [Languages] => Array ( [0] => Array ( [Text] => English ) ) [Subjects] => Array ( [0] => Array ( [SubjectFull] => Adult [Type] => general ) [1] => Array ( [SubjectFull] => Aged [Type] => general ) [2] => Array ( [SubjectFull] => 80 and over [Type] => general ) [3] => Array ( [SubjectFull] => Antineoplastic Combined Chemotherapy Protocol [Type] => general ) [4] => Array ( [SubjectFull] => Dexamethasone [Type] => general ) [5] => Array ( [SubjectFull] => Disease-Free Survival [Type] => general ) [6] => Array ( [SubjectFull] => Female [Type] => general ) [7] => Array ( [SubjectFull] => Human [Type] => general ) [8] => Array ( [SubjectFull] => Kaplan-Meier Estimate [Type] => general ) [9] => Array ( [SubjectFull] => Male [Type] => general ) [10] => Array ( [SubjectFull] => Melphalan [Type] => general ) [11] => Array ( [SubjectFull] => Middle Aged [Type] => general ) [12] => Array ( [SubjectFull] => Multiple Myeloma [Type] => general ) [13] => Array ( [SubjectFull] => Prednisone [Type] => general ) [14] => Array ( [SubjectFull] => Thalidomide [Type] => general ) [15] => Array ( [SubjectFull] => Medicine (all) [Type] => general ) ) [Titles] => Array ( [0] => Array ( [TitleFull] => Lenalidomide and dexamethasone in transplant-ineligible patients with myeloma [Type] => main ) ) ) [BibRelationships] => Array ( [HasContributorRelationships] => Array ( [0] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Benboubker, Lotfi ) ) ) [1] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Dimopoulos, Meletios A. ) ) ) [2] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Dispenzieri, Angela ) ) ) [3] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Catalano, John ) ) ) [4] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Belch, Andrew R. ) ) ) [5] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Cavo, Michele ) ) ) [6] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Pinto, Antonello ) ) ) [7] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Weisel, Katja ) ) ) [8] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Ludwig, Heinz ) ) ) [9] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Bahlis, Nizar ) ) ) [10] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Banos, Anne ) ) ) [11] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Tiab, Mourad ) ) ) [12] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Delforge, Michel ) ) ) [13] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Cavenagh, Jamie ) ) ) [14] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Geraldes, Catarina ) ) ) [15] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Lee, Je-Jung ) ) ) [16] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Chen, Christine ) ) ) [17] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Oriol, Albert ) ) ) [18] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => De La Rubia, Javier ) ) ) [19] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Qiu, Lugui ) ) ) [20] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => White, Darrell J. ) ) ) [21] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Binder, Daniel ) ) ) [22] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Anderson, Kenneth ) ) ) [23] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Fermand, Jean-Paul ) ) ) [24] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Moreau, Philippe ) ) ) [25] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Attal, Michel ) ) ) [26] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Knight, Robert ) ) ) [27] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Chen, Guang ) ) ) [28] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Van Oostendorp, Jason ) ) ) [29] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Jacques, Christian ) ) ) [30] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Ervin-Haynes, Annette ) ) ) [31] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Avet-Loiseau, Hervé ) ) ) [32] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Hulin, Cyrille ) ) ) [33] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Facon, Thierry ) ) ) [34] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => petrini, mario ) ) ) [35] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Benboubker, Lotfi ) ) ) [36] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Dimopoulos, Meletios A. ) ) ) [37] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Dispenzieri, Angela ) ) ) [38] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Catalano, John ) ) ) [39] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Belch, Andrew R. ) ) ) [40] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Cavo, Michele ) ) ) [41] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Pinto, Antonello ) ) ) [42] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Weisel, Katja ) ) ) [43] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Ludwig, Heinz ) ) ) [44] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Bahlis, Nizar ) ) ) [45] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Banos, Anne ) ) ) [46] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Tiab, Mourad ) ) ) [47] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Delforge, Michel ) ) ) [48] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Cavenagh, Jamie ) ) ) [49] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Geraldes, Catarina ) ) ) [50] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Lee, Je-Jung ) ) ) [51] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Chen, Christine ) ) ) [52] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Oriol, Albert ) ) ) [53] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => De La Rubia, Javier ) ) ) [54] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Qiu, Lugui ) ) ) [55] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => White, Darrell J. ) ) ) [56] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Binder, Daniel ) ) ) [57] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Anderson, Kenneth ) ) ) [58] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Fermand, Jean-Paul ) ) ) [59] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Moreau, Philippe ) ) ) [60] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Attal, Michel ) ) ) [61] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Knight, Robert ) ) ) [62] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Chen, Guang ) ) ) [63] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Van Oostendorp, Jason ) ) ) [64] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Jacques, Christian ) ) ) [65] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Ervin-Haynes, Annette ) ) ) [66] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Avet-Loiseau, Herv㩠) ) ) [67] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Hulin, Cyrille ) ) ) [68] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Facon, Thierry ) ) ) [69] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Petrini, Mario ) ) ) ) [IsPartOfRelationships] => Array ( [0] => Array ( [BibEntity] => Array ( [Dates] => Array ( [0] => Array ( [D] => 01 [M] => 01 [Type] => published [Y] => 2014 ) ) [Identifiers] => Array ( [0] => Array ( [Type] => issn-locals [Value] => edsbas ) ) ) ) ) ) )
IllustrationInfo